Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Other Working Capital Changes (2016 - 2025)

Enanta Pharmaceuticals' Other Working Capital Changes history spans 14 years, with the latest figure at $252000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 82.56% year-over-year to $252000.0; the TTM value through Dec 2025 reached $252000.0, down 96.62%, while the annual FY2025 figure was $379000.0, 92.41% down from the prior year.
  • Other Working Capital Changes reached $252000.0 in Q4 2025 per ENTA's latest filing, up from -$147000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $3.9 million in Q3 2024 to a low of -$5.6 million in Q3 2021.
  • Average Other Working Capital Changes over 5 years is -$328100.0, with a median of -$291500.0 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: tumbled 28335.0% in 2021, then surged 374.74% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$1.5 million in 2021, then surged by 50.92% to -$717000.0 in 2022, then plummeted by 42.68% to -$1.0 million in 2023, then surged by 241.25% to $1.4 million in 2024, then crashed by 82.56% to $252000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTA's Other Working Capital Changes are $252000.0 (Q4 2025), -$147000.0 (Q3 2025), and $314000.0 (Q2 2025).